Early studies say that people who got retatrutide lost more weight than people in the placebo group
GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone that helps regulate appetite, digestion, and insulin release, promoting a sense of fullness after meals
Your body naturally eliminates GLP-1 at its genetically predetermined rate
Monitor Progress and Adjust Plans as Needed: Regularly review the collected data to track progress, identify trends, and adjust the treatment plan as needed
Related studies have indicated a causal relationship between IR and all clinical symptoms of PCOS, with weight loss being shown to improve the reproductive function, hyperandrogenism and metabolism of women with PCOS (155, 156)
Phase 3 clinical trial data found that Foundayo helped people lose 12.4% of their weight, on average, at its highest dose after 72 weeks similar to the Wegovy pill but less than injectable versions of Wegovy and Zepbound